LINNANE PHARMA AB has a total of 33 patent applications. It decreased the IP activity by 84.0%. Its first patent ever was published in 2016. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ROUSSY INST GUSTAVE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE) and XINJIANG ACADEMY OF ANIMAL SCIENCES VETERINARY RES INSTITUTE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Australia | 2 | |
#6 | Singapore | 2 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Measuring microorganism processes | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Svanborg Catharina | 21 |
#2 | Ambite Ines | 11 |
#3 | Cafaro Caterina | 5 |
#4 | Filenko Nina | 5 |
#5 | Puthia Manoj | 3 |
#6 | Butler Daniel Sebastian Christopher | 3 |
#7 | Godaly Gabriela Zuzana Victoria | 2 |
#8 | Tenland Erik Olof | 2 |
#9 | Wullt Björn | 1 |
#10 | Ambites Ines | 1 |
Publication | Filing date | Title |
---|---|---|
GB202017598D0 | Therapy | |
WO2020245464A1 | Treatment and diagnosis of chronic inflammatory conditions in the lower urinary tract | |
GB202001320D0 | Novel Therapy | |
GB201919177D0 | Novel therapy | |
GB201919036D0 | Therapy | |
GB201912423D0 | Novel therapy | |
GB201908884D0 | Inhibitors and use | |
CA3108344A1 | Peptides with antibiotic potential against mycobacterium tuberculosis | |
US2020155534A1 | Novel therapy | |
GB201702601D0 | Novel therapy | |
GB201617548D0 | Novel biological factor | |
GB201617470D0 | Novel therapy | |
GB201611900D0 | Novel therapy | |
EP3242680A2 | Novel therapy |